Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis
Federico Oldoni, Damiano Baldassarre, S. Castelnuovo, et al.
Circulation (2018) Vol. 138, Iss. 10, pp. 1000-1007
Open Access | Times Cited: 65

Showing 26-50 of 65 citing articles:

Update on the diagnosis, treatment and management of rare genetic lipid disorders
David Ng, John R. Burnett, Damon A. Bell, et al.
Pathology (2018) Vol. 51, Iss. 2, pp. 193-201
Closed Access | Times Cited: 16
Activation of Naturally Occurring Lecithin:Cholesterol Acyltransferase Mutants by a Novel Activator Compound
Chiara Pavanello, Alice Ossoli, Marta Turri, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 375, Iss. 3, pp. 463-468
Open Access | Times Cited: 14
Spontaneous Atherosclerosis in Aged LCAT-Deficient Hamsters With Enhanced Oxidative Stress—Brief Report
Mengmeng Guo, Liu Zong-yu, Yitong Xu, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 40, Iss. 12, pp. 2829-2836
Open Access | Times Cited: 13
Primary genetic disorders affecting high density lipoprotein (HDL)
Constantine E. Kosmas, Delia Silverio, Andreas Sourlas, et al.
Drugs in Context (2018) Vol. 7, pp. 1-11
Open Access | Times Cited: 14
Is Low-Density Lipoprotein Cholesterol the Key to Interpret the Role of Lecithin:Cholesterol Acyltransferase in Atherosclerosis?
Cecilia Vitali, Alan T. Remaley, Marina Cuchel
Circulation (2018) Vol. 138, Iss. 10, pp. 1008-1011
Open Access | Times Cited: 14
The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred
Nikolaos Fountoulakis, Eirini Lioudaki, Dimitra Lygerou, et al.
American Journal of Kidney Diseases (2019) Vol. 74, Iss. 4, pp. 510-522
Closed Access | Times Cited: 12
Current Status of Familial LCAT Deficiency in Japan
Masayuki Kuroda, Hideaki Bujo, Koutaro Yokote, et al.
Journal of Atherosclerosis and Thrombosis (2021)
Open Access | Times Cited: 11
The anti-hyperlipidemia effect of Atractylodes macrocephala Rhizome increased HDL via reverse cholesterol transfer
Bo Li, Xian-fang Chen, Han-song Wu, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28019-e28019
Open Access | Times Cited: 1
Systematic evaluation of lecithin:cholesterol acyltransferase binding sites in apolipoproteins via peptide based nanodiscs: regulatory role of charged residues at positions 4 and 7
Akseli Niemelä, Artturi Koivuniemi
PLoS Computational Biology (2024) Vol. 20, Iss. 5, pp. e1012137-e1012137
Open Access | Times Cited: 1
Rescue of Familial Lecithin:Cholesterol Acyltranferase Deficiency Mutations with an Allosteric Activator
Kelly A. Manthei, Grace E. Tremonti, Louise Chang, et al.
Molecular Pharmacology (2024) Vol. 106, Iss. 4, pp. 188-197
Open Access | Times Cited: 1
Emerging Biomarkers and Determinants of Lipoprotein Profiles to Predict CVD Risk: Implications for Precision Nutrition
Catherine J. Andersen, María Luz Fernández
Nutrients (2024) Vol. 17, Iss. 1, pp. 42-42
Open Access | Times Cited: 1
Genetic Lipid Disorders Associated with Atherosclerotic Cardiovascular Disease
Reed Mszar, Gayley Webb, Vivek Kulkarni, et al.
Medical Clinics of North America (2022) Vol. 106, Iss. 2, pp. 325-348
Closed Access | Times Cited: 7
Mechanistic Insights into the Activation of Lecithin–Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids
Laura Giorgi, Akseli Niemelä, Esa‐Pekka Kumpula, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 11, pp. 4135-4148
Open Access | Times Cited: 7
Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challenges
Cecilia Vitali, Daniel J. Rader, Marina Cuchel
Current Opinion in Lipidology (2022) Vol. 34, Iss. 2, pp. 35-43
Closed Access | Times Cited: 7
Lysophospholipid profiles of apolipoprotein E-deficient mice reveal potential lipid biomarkers associated with atherosclerosis progression using validated UPLC-QTRAP-MS/MS-based lipidomics approach
Yingfei Yan, Zhifeng Du, Chang Chen, et al.
Journal of Pharmaceutical and Biomedical Analysis (2019) Vol. 171, pp. 148-157
Closed Access | Times Cited: 10
Inheritance of high and low HDL: mechanisms and management
Andreas Sourlas, Constantine E. Kosmas
Current Opinion in Lipidology (2019) Vol. 30, Iss. 4, pp. 307-313
Closed Access | Times Cited: 10
Genetics and regulation of HDL metabolism
Dimitris Kardassis, Efstathia Thymiakou, Angeliki Chroni
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1867, Iss. 1, pp. 159060-159060
Closed Access | Times Cited: 9
Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans
Chiara Pavanello, Alice Ossoli, Arianna Strazzella, et al.
Journal of Lipid Research (2022) Vol. 63, Iss. 7, pp. 100232-100232
Open Access | Times Cited: 6
Inherited metabolic disorders and dyslipidaemia
Raashda A. Sulaiman
Journal of Clinical Pathology (2019) Vol. 73, Iss. 7, pp. 384-390
Closed Access | Times Cited: 8
Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis
Cecilia Vitali, Marina Cuchel
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 1, pp. 377-379
Open Access | Times Cited: 7
Angeborene Störungen des High-density-Lipoprotein-Stoffwechsels
Arnold von Eckardstein
Der Internist (2019) Vol. 60, Iss. 12, pp. 1311-1318
Closed Access | Times Cited: 6
Apolipoprotein E isoforms differentially affect LCAT-dependent cholesterol esterification
Cecilia Vitali, Chiara Pavanello, Marta Turri, et al.
Atherosclerosis (2023) Vol. 382, pp. 117266-117266
Closed Access | Times Cited: 2
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis
Alice Ossoli, Ilenia Minicocci, Marta Turri, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1868, Iss. 3, pp. 159263-159263
Closed Access | Times Cited: 4
Genetically Compromising Phospholipid Metabolism Limits Candida albicans’ Virulence
Dorothy Wong, James Plumb, Hosamiddine Talab, et al.
Mycopathologia (2019) Vol. 184, Iss. 2, pp. 213-226
Closed Access | Times Cited: 5
Correction of Familial LCAT Deficiency by AAV-hLCAT Prevents Renal Injury and Atherosclerosis in Hamsters—Brief Report
Mengmeng Guo, Sisi Ma, Yitong Xu, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 7, pp. 2141-2148
Open Access | Times Cited: 5

Scroll to top